BioXcel Therapeutics, Inc.

BTAI

BioXcel Therapeutics, Inc.

BTAI

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-05-20Shares Purchased (TTM):0Shares Sold (TTM):39,669

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:5,441,350Shares Outstanding:23,571,000Institutional Ownership Pct.:23.08%

Earnings Market Reaction:

Filing Date:2026-05-15Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

BioXcel Therapeutics, Inc. (BTAI) — SEC Financial Statements & Analysis

BioXcel Therapeutics, Inc. (BTAI) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Related Party	0	0	0	0	0	0	0	0	0	0	-	-
Nonrelated Party	10	10	-0	-0	0	0	0	0	0	0	-	-
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	17	28	36	17	31	30	40	56	74	65	90	128
Restricted Cash Current	0	0	1	1	-	0	0	-	-	-	-	-
Receivables Net Current	0	0	0	0	-	0	0	1	0	0	1	0
Inventory Net	1	1	0	1	1	1	2	3	2	2	2	2
Prepaid Expense And Other Assets Current	4	4	6	5	5	5	4	3	2	3	4	4
Other Assets Current	12	11	1	1	1	1	1	2	2	2	2	5
Assets Current	34	45	44	25	38	37	48	64	81	72	99	138
Property Plant And Equipment Net	0	0	0	0	0	0	1	1	1	1	1	1
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	1	1	1	1	1
Other Assets Noncurrent	-	0	0	-	0	0	0	0	0	0	0	0
Assets	34	45	45	26	39	38	49	65	82	74	100	140
Liabilities And Stockhold…
Liabilities Current
Due To Related Parties Current	-	-	-	-	-	-	-	-	-	-	1	1
Accounts Payable Current	16	15	16	17	15	16	15	13	17	14	11	11
Accrued Liabilities Current	6	4	4	5	4	6	10	13	14	12	27	19
Interest Payable Current	-	-	-	-	-	-	-	0	0	1	1	3
Other Liabilities Current	-	-	-	-	-	-	-	-	-	-	1	0
Long Term Debt Current	22	25	17	11	6	0	-	-	-	-	-	-
Liabilities Current	55	54	38	33	26	22	26	27	31	27	39	35
Operating Lease Liability Noncurrent	-	0	0	-	-	0	0	0	0	0	1	1
Derivative Liabilities Noncurrent	7	2	4	3	3	7	4	9	21	2	2	2
Long Term Debt Noncurrent	78	85	92	97	100	103	104	103	102	101	99	97
Liabilities	140	140	134	133	129	131	135	140	155	130	141	134
Stockholders Equity
Preferred Stock Value	0	0	0	0	-	0	-	-	-	-	-	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	627	625	619	569	567	557	554	551	545	534	528	524
Retained Earnings Accumulated Deficit	-733	-720	-708	-677	-657	-650	-639	-626	-617	-591	-568	-518
Stockholders Equity	-106	-95	-89	-108	-90	-93	-86	-74	-72	-57	-41	6
Liabilities And Stockholders Equity	34	45	45	26	39	38	49	65	82	74	100	140
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	54	45	40	40	44	43	42	40	34	2	2	2
Shares Outstanding	54	45	40	40	44	43	42	40	34	2	29	29

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-3.07%	21.05%	-	-	-	-	-	-	-	-	-	-
2025	24.32%	30.41%	-7.43%	-44.26%	-62.79%	-69.85%	21.05%	-0.58%	-7.02%	-8.73%	-9.52%	-9.52%
2024	-21.48%	-44.47%	-50.11%	-35.94%	-37.19%	-36.35%	-21.54%	-20.38%	-37.31%	-17.92%	-31.60%	-26.42%
2023	-	-	-	-13.63%	-35.10%	7.16%	-24.88%	-33.41%	-27.49%	3.20%	-25.62%	-49.64%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	0.62	0.83	1.17	0.76	1.48	1.68	1.87	2.35	2.57	2.65	2.51	3.98
Quick Ratio	0.54	0.74	1.01	0.59	1.27	1.41	1.64	2.15	2.43	2.47	2.36	3.82
Working Capital	-21.09M	-9.24M	6.60M	-8.13M	12.23M	15.16M	22.24M	36.89M	49.44M	44.88M	59.33M	103.49M
Leverage & Debt
Debt to Equity	-1.32	-1.47	-1.50	-1.24	-1.43	-1.41	-1.57	-1.88	-2.14	-2.30	-3.47	22.89
Interest Coverage TTM	-	-	-	-	-	-18.64	-10.88	-10.65	-10.68	-12.90	-16.00	-14.76
Debt Ratio	4.10	3.13	2.99	5.17	3.34	3.43	2.75	2.14	1.88	1.77	1.40	0.96
Efficiency & Turnover
Asset Turnover TTM	0.02	0.02	0.02	0.02	0.03	0.04	0.03	0.02	0.01	0.01	0.01	0.01
Days Sales Outstanding TTM	115.94	103.47	-	174.30	-	16.27	59.18	94.40	68.70	42.19	216.00	151.56
Receivables Turnover TTM	3.15	3.53	-	2.09	-	22.44	6.17	3.87	5.31	8.65	1.69	2.41
Per Share Metrics
Diluted EPS TTM	-3.20	-2.86	-2.40	-3.25	-4.14	-11.76	-13.40	-21.43	-39.67	-49.16	-54.22	-52.14
Free Cash Flow Per Share TTM	-2.43	-2.36	-2.05	-3.56	-6.86	-14.21	-15.87	-20.93	-31.20	-42.57	-42.74	-41.22
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	36.32%	74.45%	-28.06%	-144.47%	-12.15%	5.43%	11.03%	43.11%	24.20%	8.70%	55.23%	94.70%
Operating Profit Margin TTM	-7,438.97%	-7,859.97%	-6,738.30%	-5,960.48%	-2,871.54%	-2,967.56%	-3,366.65%	-4,562.17%	-8,243.00%	-12,447.97%	-16,489.21%	-18,833.24%
Net Profit Margin TTM	-11,078.53%	-10,887.38%	-9,070.61%	-5,869.82%	-2,163.17%	-2,630.14%	-3,119.33%	-4,487.39%	-8,715.72%	-12,974.86%	-17,037.60%	-19,549.71%
Growth Metrics
Net Revenue Growth (1Y)	-63.28%	-71.67%	-66.96%	-63.88%	5.47%	64.20%	83.25%	131.50%	202.24%	268.00%	806.57%	-
Net Income Growth (1Y)	88.04%	17.28%	-3.92%	-52.75%	-73.82%	-66.71%	-66.45%	-46.86%	-18.19%	8.02%	54.38%	66.23%
EPS Growth (1Y)	-22.87%	-75.65%	-82.07%	-84.84%	-89.55%	-76.09%	-75.29%	-58.90%	-19.09%	10.79%	47.80%	59.40%
Valuation Metrics
P/E TTM	-0.42	-0.56	-1.07	-0.56	-0.49	-0.51	-0.73	-0.96	-1.14	-0.96	-0.75	-2.04
P/B	-0.30	-0.41	-0.82	-0.26	-0.22	-0.33	-0.60	-1.39	-2.41	-3.04	-3.89	70.72
P/S TTM	46.45	60.85	96.65	32.71	10.60	13.39	22.72	42.89	99.13	124.57	127.19	399.51
Market Cap	31.59M	39.07M	72.68M	28.39M	19.63M	30.34M	51.71M	103.06M	174.07M	171.90M	157.97M	414.69M
Enterprise Value	114.69M	119.90M	144.49M	118.50M	94.14M	102.99M	115.76M	149.79M	201.56M	207.28M	167.10M	383.99M
Calculated Values
Free Cash Flow TTM	-57.38M	-57.62M	-58.21M	-55.77M	-66.36M	-72.03M	-84.08M	-105.33M	-120.38M	-155.03M	-166.80M	-160.40M
Net Debt	83.11M	80.84M	71.81M	90.11M	74.51M	72.65M	64.05M	46.74M	27.49M	35.38M	9.13M	-30.70M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-20Sale

Owner: Mehta, Vimal

Title: CEO and President

Shares: 19,419

Price/Share: $1.09

Value: $21,166.71

Shares Owned: 69,598

Relationship: Director,Officer

Ownership: Direct

2026-05-20Sale

Owner: Yocca, Frank

Title: Chief Scientific Officer

Shares: 6,845

Price/Share: $1.09

Value: $7,461.05

Shares Owned: 26,175

Relationship: Officer

Ownership: Direct

2026-05-20Sale

Owner: Steinhart, Richard I

Title: Chief Financial Officer

Shares: 6,845

Price/Share: $1.09

Value: $7,461.05

Shares Owned: 26,300

Relationship: Officer

Ownership: Direct

2026-05-20Sale

Owner: Rodriguez, Javier

Title: See Remarks

Shares: 6,560

Price/Share: $1.08

Value: $7,084.80

Shares Owned: 26,803

Relationship: Officer

Ownership: Direct

2024-12-16Sale

Owner: Rodriguez, Javier

Title: See Remarks

Shares: 430

Price/Share: $0.36

Value: $154.80

Shares Owned: 24,423

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-20	Mehta, Vimal	Director,Officer	CEO and President	Direct	Sale	19,419	1.09	$21,166.71	69,598	4
2026-05-20	Yocca, Frank	Officer	Chief Scientific Officer	Direct	Sale	6,845	1.09	$7,461.05	26,175	4
2026-05-20	Steinhart, Richard I	Officer	Chief Financial Officer	Direct	Sale	6,845	1.09	$7,461.05	26,300	4
2026-05-20	Rodriguez, Javier	Officer	See Remarks	Direct	Sale	6,560	1.08	$7,084.80	26,803	4
2024-12-16	Rodriguez, Javier	Officer	See Remarks	Direct	Sale	430	0.36	$154.80	24,423	4
2024-12-16	O'Neill, Vincent	Officer	See Remarks	Direct	Sale	165	0.35	$57.75	19,957	4
2024-12-16	Yocca, Frank	Officer	Chief Scientific Officer	Direct	Sale	430	0.36	$154.80	28,931	4
2024-12-16	Mehta, Vimal	Director,Officer,TenPercentOwner	CEO and President	Direct	Sale	3,117	0.36	$1,122.12	59,605	4
2024-12-16	Steinhart, Richard I	Officer	Chief Financial Officer	Direct	Sale	577	0.36	$207.72	20,932	4
2024-10-03	Wiley, Matthew T.	Officer	Chief Commercial Officer	Direct	Sale	6,272	0.55	$3,449.60	19,011	4
2024-10-03	Rodriguez, Javier	Officer	See Remarks	Direct	Sale	6,863	0.55	$3,774.65	23,770	4
2024-10-03	Steinhart, Richard I	Officer	Chief Financial Officer	Direct	Sale	7,175	0.55	$3,946.25	20,279	4
2024-10-03	Yocca, Frank	Officer	Chief Scientific Officer	Direct	Sale	7,175	0.55	$3,946.25	28,278	4
2024-10-03	O'Neill, Vincent	Officer	See Remarks	Direct	Sale	5,556	0.55	$3,055.80	19,601	4
2024-09-16	Steinhart, Richard I	Officer	Chief Financial Officer	Direct	Sale	356	0.69	$245.64	6,204	4
2024-09-16	O'Neill, Vincent	Officer	See Remarks	Direct	Sale	138	0.69	$95.22	3,907	4
2024-09-16	Yocca, Frank	Officer	Chief Scientific Officer	Direct	Sale	355	0.69	$244.95	14,203	4
2024-09-16	Rodriguez, Javier	Officer	See Remarks	Direct	Sale	345	0.69	$238.05	9,133	4
2024-09-16	Mehta, Vimal	Director,Officer,TenPercentOwner	CEO and President	Direct	Sale	1,982	0.69	$1,367.58	51,666	4
2024-09-16	Wiley, Matthew T.	Officer	Chief Commercial Officer	Direct	Sale	215	0.69	$148.35	4,033	4
2024-06-17	Steinhart, Richard I	Officer	Chief Financial Officer	Direct	Sale	372	1.26	$468.72	5,476	4
2024-06-17	Wiley, Matthew T.	Officer	Chief Commercial Officer	Direct	Sale	244	1.26	$307.44	3,498	4
2024-06-17	Yocca, Frank	Officer	Chief Scientific Officer	Direct	Sale	372	1.28	$476.16	13,474	4
2024-06-17	O'Neill, Vincent	Officer	See Remarks	Direct	Sale	155	1.29	$199.95	3,524	4
2024-06-17	Mehta, Vimal	Director,Officer,TenPercentOwner	CEO and President	Direct	Sale	2,134	1.28	$2,731.52	47,539	4
2024-06-17	Rodriguez, Javier	Officer	See Remarks	Direct	Sale	361	1.26	$454.86	8,394	4
2024-06-05	Bioxcel, Holdings, Inc., …	Director,Officer,TenPercentOwner	CEO and President	Indirect	Sale	409,136	1.58	$646,434.88	0	4
2024-04-04	Rodriguez, Javier	Officer	See Remarks	Direct	Sale	1,012	2.64	$2,671.68	7,672	4
2024-04-04	Wiley, Matthew T.	Officer	CHIEF COMMERCIAL OFFICER	Direct	Sale	1,008	2.64	$2,661.12	2,992	4
2024-04-04	Steinhart, Richard I	Officer	Chief Financial Officer	Direct	Sale	1,069	2.64	$2,822.16	4,765	4
2024-04-04	Mehta, Vimal	Director,Officer	CEO and President	Direct	Sale	5,268	2.62	$13,802.16	43,564	4
2024-04-04	O'Neill, Vincent	Officer	See Remarks	Direct	Sale	165	2.62	$432.30	5,408	4
2024-04-04	Yocca, Frank	Officer	Chief Scientific Officer	Direct	Sale	1,067	2.64	$2,816.88	12,763	4
2023-06-16	Mehta, Vimal	Director,Officer	CEO and President	Direct	Sale	30,000	20.93	$627,900.00	39,903	4
2023-05-22	Mehta, Vimal	Director,Officer	CEO and President	Direct	Sale	6,500	25.79	$167,635.00	37,294	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

23.08%

Inst. Shares: 5,441,350

Shares Outstanding: 23,571,000

2025-12-31

13.93%

Inst. Shares: 3,400,517

Shares Outstanding: 24,416,000

2025-09-30

8.29%

Inst. Shares: 2,353,307

Shares Outstanding: 28,392,000

2025-06-30

3.91%

Inst. Shares: 613,025

Shares Outstanding: 15,686,000

2025-03-31

3.79%

Inst. Shares: 366,417

Shares Outstanding: 9,668,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	5,441,350	23,571,000	23.08%
2025-12-31	3,400,517	24,416,000	13.93%
2025-09-30	2,353,307	28,392,000	8.29%
2025-06-30	613,025	15,686,000	3.91%
2025-03-31	366,417	9,668,000	3.79%
2024-12-31	8,448,036	5,070,000	166.63%
2024-09-30	2,995,672	5,298,000	56.54%
2024-06-30	9,477,845	5,032,000	188.35%
2024-03-31	9,092,609	3,858,000	235.68%
2023-12-31	9,135,051	3,642,000	250.83%
2023-09-30	10,067,103	3,902,400	257.97%
2023-06-30	17,510,189	3,891,600	-
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

BioXcel Therapeutics, Inc. (BTAI) — SEC Financial Statements & Analysis

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.